- Home
- SNGX vs AMIX Comparison
SNGX vs AMIX Comparison
Compare SNGX & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- AMIX
- Stock Information
- Founded
- SNGX 1987
- AMIX 2014
- Country
- SNGX United States
- AMIX United States
- Employees
- SNGX N/A
- AMIX N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- SNGX Health Care
- AMIX
- Exchange
- SNGX Nasdaq
- AMIX NYSE
- Market Cap
- SNGX 6.1M
- AMIX 5.5M
- IPO Year
- SNGX 1987
- AMIX N/A
- Fundamental
- Price
- SNGX $1.89
- AMIX $1.63
- Analyst Decision
- SNGX
- AMIX
- Analyst Count
- SNGX 0
- AMIX 0
- Target Price
- SNGX N/A
- AMIX N/A
- AVG Volume (30 Days)
- SNGX 29.1K
- AMIX 41.1K
- Earning Date
- SNGX 05-09-2025
- AMIX 02-13-2025
- Dividend Yield
- SNGX N/A
- AMIX N/A
- EPS Growth
- SNGX N/A
- AMIX N/A
- EPS
- SNGX N/A
- AMIX N/A
- Revenue
- SNGX $119,371.00
- AMIX N/A
- Revenue This Year
- SNGX N/A
- AMIX N/A
- Revenue Next Year
- SNGX N/A
- AMIX N/A
- P/E Ratio
- SNGX N/A
- AMIX N/A
- Revenue Growth
- SNGX N/A
- AMIX N/A
- 52 Week Low
- SNGX $1.83
- AMIX $1.52
- 52 Week High
- SNGX $14.88
- AMIX $75.80
- Technical
- Relative Strength Index (RSI)
- SNGX 33.66
- AMIX 33.18
- Support Level
- SNGX $2.25
- AMIX $1.52
- Resistance Level
- SNGX $2.28
- AMIX $1.78
- Average True Range (ATR)
- SNGX 0.11
- AMIX 0.16
- MACD
- SNGX -0.02
- AMIX 0.00
- Stochastic Oscillator
- SNGX 0.11
- AMIX 24.66
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.